Developing in emerging markets and innovating specialized solutions offers growth potential, amid rising cancer prevalence and patient-centered care trends.
Oncology Nutrition Market
Oncology Nutrition Market ·GlobeNewswire Inc.
Dublin, March 27, 2026 (GLOBE NEWSWIRE) — The “Oncology Nutrition Market Report 2026” has been added to ResearchAndMarkets.com’s offer.
The oncology nutrition market has shown strong growth, growing from $2.08 billion in 2025 to $2.28 billion in 2026, with a CAGR of 9.6%. This growth is driven by increasing awareness of the role of nutrition in cancer care, the prevalence of various types of cancer, and the adoption of advanced nutritional interventions in both clinical and home settings. The development of special formulas and the establishment of specialized clinics focused on cancer treatment have contributed to this trend.
Projections show that the oncology nutrition market will continue its strong expansion, reaching $3.27 billion by 2030 with a CAGR of 9.4%. Factors contributing to this growth include the demand for personalized nutrition plans, the integration of technology in nutrition tracking, and a focus on improving patient outcomes. Emerging markets are seeing expanded services, supported by trends such as digital health platforms, AI-driven diet planning, and IoT monitoring systems.
The rising number of cancer cases has been a significant growth driver for the oncology nutrition market. The World Health Organization report projects more than 35 million new cancer cases worldwide by 2050, a dramatic increase from the estimated 20 million in 2022. This surge underlines the need for nutritional solutions focused on oncology, highlighting the expansion of the market.
Leading companies in the oncology nutrition sector are innovating to improve treatment outcomes. They focus on developing nutritional programs that support immune function and manage side effects associated with therapy, which ultimately aims to improve the quality of life of cancer patients. For example, AEACAP in Spain launched a nutrition education series in June 2024, offered twice a week and featuring guidance from specialized nutritionists. This initiative emphasizes the important role of nutrition in the efficacy of treatment.
In a notable collaboration, Danone SA partnered with National Resilience, Inc. in January 2024 to integrate the nutrition support module into the digital oncology platform, to overcome the challenge of malnutrition during cancer treatment. This collaboration highlights efforts to improve nutrition care through digital solutions.
Major players in the market include B. Braun Melsungen AG, Abbott Laboratories, Nestle SA, Nutricia, Baxter International Inc., and Danone SA, among others. These companies are instrumental in advancing nutritional solutions tailored to specific types of cancer, including blood, breast, and gastrointestinal cancers. Services in this area typically involve enteral and parenteral nutrition available in hospital and homecare settings.
Geographically, North America dominates the oncology nutrition market by 2025, while Asia-Pacific is poised to be the fastest growing region during the forecast period.
Scope of the Report
The report answers a critical question: What are the largest and fastest growing regions for oncology nutrition? How does the market align with broader economic and demographic factors? It covers market characteristics, segmentation, growth rates, and country-specific analysis.
Market characteristics determine products and services, brand differentiation, and innovation trends.
The supply chain analysis section offers a comprehensive overview, including key ingredients and supplier assessments.
Updated trends and strategies outline market evolution and emerging technologies such as digital transformation and AI innovation.
The regulatory landscape section reviews the key frameworks and investment streams that affect market dynamics.
Market size is presented in monetary terms, covering past growth and future projections considering technological and geopolitical factors.
TAM analysis evaluates the market’s potential relative to its current size, offering strategic growth opportunities.
The market attractiveness score uses a quantitative framework to evaluate growth potential and the competitive landscape.
Segmentation divides the market into sub-markets.
Expanded geographic coverage to include a focus on Taiwan and the Southeast Asian region, reflecting recent shifts in supply chains and manufacturing.
The competitive landscape chapter describes the competitive nature of the market, highlighting major companies and their financial offerings.
The company’s scoring matrix ranks leading firms based on parameters such as market share, innovation, and brand strength.
Markets Covered:
By Cancer Type: Blood Cancer; Breast cancer; Stomach and gastrointestinal cancer; Liver Cancer; Pancreatic cancer; Other types of Cancer
By Nutrition: Enteral Nutrition; Parenteral nutrition
By End-User: Hospital; Homecare; Special clinics; Other End Users
Pancreas: Exocrine; Tumors of the Endocrine Pancreas
Other types: Lung; prostate; ovaries; Head and Neck Cancer
Company Named: B. Braun Melsungen AG, Abbott Laboratories, Nestle SA, Nutricia, Baxter International Inc., Fresenius Kabi AG, Danone SA, Ajinomoto Co Ltd, and others.
Country: Australia, Brazil, China, France, Germany, India, Japan, Russia, England, USA, and more.
Area: Asia-Pacific, Western and Eastern Europe, North and South America, Middle East, Africa
Time series: Five-year historical data and ten-year forecast.
Data: Includes market size ratios, GDP connections, and per capita expenditure data.
Data Segmentation: Offers country and regional data, competitive market share, and segments.
Delivery Format: Available in Word, PDF, or interactive reports and Excel dashboards.
Key attributes
Report Attributes
details
Number of Pages
250
Forecast Period
2026-2030
Estimated Market Value (USD) in 2026
$2.28 Billion
Forecast Market Value (USD) by 2030
$3.27 Billion
Compound Annual Growth Rate
9.4%
Area Covered
Global
Companies featured in this Oncology Nutrition market report include:
B. Braun Melsungen AG
Abbott Laboratories
Abbott Nutrition
Nestle SA
Nutritionist
Baxter International Inc.
Fresenius Kol AG
Fresenius Kabi USA LLC
Global Health Products Inc.
Cambrooke Therapeutics Inc.
Kate Farms Inc.
Real Food Blends LLC
Medtrition Inc.
Nutra Balance Products
Nutritional Medicinals LLC
Primus Pharmaceuticals Inc.
Nutrition Solace
Unimed Pharma LLC
Vitaflo AS LLC
Danone SA
Ajinomoto Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Grifols SA
Food Inc.
Nutrition of Hope
For more information on this report please visit https://www.researchandmarkets.com/r/teeo2w
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For Office Hours EST Call 1-917-300-0470 For US/CAN Toll Free Call 1-800-526-8630 For Office Hours GMT Call +353-1-4016-89
